$LLY: Eli Lilly and Boehringer Ingelheim’s Tradjenta successful in CV …

Date: Thursday, February 14th, 2019

Stock(s) mentioned:

Source: Seeking Alpha (https://seekingalpha.com)

Summary: Eli Lilly (NYSE:LLY) and alliance partner Boehringer Ingelheim announce that the CAROLINA study assessing cardiovascular (CV) outcomes in type 2 diabetics …

Full article address: https://seekingalpha.com/news/3433257-eli-lilly-boehringer-ingelheims-tradjenta-successful-cv-outcome-study

Related News:

$LLY $LOXO: Lilly finalizes Loxo buy

$LLY $LOXO: Lilly Completes Acquisition of Loxo Oncology

$LLY: Boehringer Ingelheim and Lilly announce the CAROLINA …

$LLY: meets primary endpoint of non-inferiority compared to glimepiride

$SLIM $ABT $AMGN $HCA $LLY $MDGL: How to Fatten Up Your Portfolio By Investing in the Obesity Epidemic

$LLY: Lilly launches exchange offer for Elanco shares

$LLY: Lilly Will Initiate Divestiture of its Remaining Interest in Elanco …

$LLY: Eli Lilly & Co (LLY) Q4 2019 Earnings Conference Call Transcript

$LLY: Eli Lilly and Company (LLY) CEO Dave Ricks on Q4 2018 Results …

$FOXA $LLY: After State Of the Union, Focus Turns Again To Earnings News …

$GM $DIS $LLY $LOXO $FOXA $AMZN: Dow Falls as Wall Street Gets No Boost From State of the Union

Latest News:

$NVDA: Nvidia: Incongruous Guidance

$WLK: Building Products Inspires Pros to “Build Royal™” with New Colors …

$PPG: PPG, PPG Foundation Invested More than $9 Million in …

$ABB: ABB Customer World Sneak Peak: Announcing our Exciting Keynote …

$CUB: Cubic Appoints Mick Spiers as General Manager for Singapore …

$HOG: Harley-Davidson surges back on list of nation’s most intimate brands

$NFLX $DIS: Is the Market Falling Out of Love With FAANG Stocks?

$SGA: Saga Communications, Inc. Announces Date and Time of 4th …

$CGC $TLRY: Barron’s On: Marijuana Stocks

$AMZN $XPO: Amazon Strikes a Blow in the Logistics Industry

$HD $SMG: Better Buy: Scotts Miracle-Gro vs. The Home Depot